Clinical trial NCT00846326 - References

Allergic Rhinitis — Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

Citation(s)

•   Bousquet J, Van Cauwenberge P, Khaltaev N; Aria Workshop Group; World Health Organization
  Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001 Nov;108(5 Suppl):S147-334. Review.
•   Davies AO, Lefkowitz RJ
  Regulation of beta-adrenergic receptors by steroid hormones. Annu Rev Physiol. 1984;46:119-30. Review.
•   Ferguson BJ
  Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004 May;130(5):617-29. Review.
•   Graf P
  Long-term use of oxy- and xylometazoline nasal sprays induces rebound swelling, tolerance, and nasal hyperreactivity. Rhinology. 1996 Mar;34(1):9-13.
•   Gupta R, Sheikh A, Strachan DP, Anderson HR
  Burden of allergic disease in the UK: secondary analyses of national databases. Clin Exp Allergy. 2004 Apr;34(4):520-6.
•   Hallén H, Enerdal J, Graf P
  Fluticasone propionate nasal spray is more effective and has a faster onset of action than placebo in treatment of rhinitis medicamentosa. Clin Exp Allergy. 1997 May;27(5):552-8.
•   Hamamdzic D, Duzic E, Sherlock JD, Lanier SM
  Regulation of alpha 2-adrenergic receptor expression and signaling in pancreatic beta-cells. Am J Physiol. 1995 Jul;269(1 Pt 1):E162-71.
•   Nassef M, Shapiro G, Casale TB; Respiratory and Allergic Disease Foundation
  Identifying and managing rhinitis and its subtypes: allergic and nonallergic components--a consensus report and materials from the Respiratory and Allergic Disease Foundation. Curr Med Res Opin. 2006 Dec;22(12):2541-8.
•   Nolte H, Nepper-Christensen S, Backer V
  Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006 Feb;100(2):354-62. Epub 2005 Jul 11.
•   Patou J, De Smedt H, van Cauwenberge P, Bachert C
  Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy. 2006 Aug;36(8):972-81.
•   Petruson B
  Treatment with xylometazoline (Otrivin) nosedrops over a six-week period. Rhinology. 1981 Sep;19(3):167-72.
•   Ramey JT, Bailen E, Lockey RF
  Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-55. Review.
•   Tan KS, Grove A, McLean A, Gnosspelius Y, Hall IP, Lipworth BJ
  Systemic corticosteriod rapidly reverses bronchodilator subsensitivity induced by formoterol in asthmatic patients. Am J Respir Crit Care Med. 1997 Jul;156(1):28-35.
•   Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR
  Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology. 2003 Sep;41(3):167-74.
•   Yoo JK, Seikaly H, Calhoun KH
  Extended use of topical nasal decongestants. Laryngoscope. 1997 Jan;107(1):40-3.

A Proof of Concept Study to Evaluate if Concomitant Topical Intranasal Steroid Prevents Tolerance and Rebound Congestion Due to Regular Oxymetazoline in Persistent Allergic Rhinitis.

Details for clinical trial NCT00846326